NEW YORK (GenomeWeb News) – Genomics services company Ambry Genetics said Tuesday that it has been certified to provide services at its California lab using Agilent Technologies' microarray platforms.

Ambry Genetics said it passed an assessment program to provide comparative genomic hybridization services to detect genomic copy number variations in specific genomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.